The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022

被引：50
作者：
Pang, Xiaojing [1 ]
Liu, Yang [1 ]
Li, Hua [1 ,2 ]
Chen, Lixia [1 ]
机构：
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Inst Struct Pharmacol & TCM Chem Biol, Coll Pharm, Fuzhou 350122, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 257卷
基金：
中国国家自然科学基金;
关键词：
COVID-19; SARS-CoV-2; M pro inhibitors; Drug repurposing; Drug design; COVALENT INHIBITORS; GENOME SEQUENCE; ACHILLES-HEEL; CORONAVIRUS; DISCOVERY; EBSELEN; IDENTIFICATION; REPLICATION; DESIGN; 3C;
D O I：
10.1016/j.ejmech.2023.115491
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The main protease (Mpro) of SARS-CoV-2 plays a central role in viral replication and transcription and represents an attractive drug target for fighting COVID-19. Many SARS-CoV-2 Mpro inhibitors have been reported, including covalent and noncovalent inhibitors. The SARS-CoV-2 Mpro inhibitor PF-07321332 (Nirmatrelvir) designed by Pfizer has been put on the market. This paper briefly introduces the structural characteristics of SARS-CoV-2 Mpro and summarizes the research progress of SARS-CoV-2 Mpro inhibitors from the aspects of drug repurposing and drug design. These information will provide a basis for the drug development of treating the infection of SARS-CoV-2 and even other coronaviruses in the future.
引用
收藏
页数：20
相关论文
共 50 条
  • [41] Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
    Abel, Renata
    Ramos, Maria Paredes
    Chen, Qiaofeng
    Perez-Sanchez, Horacio
    Coluzzi, Flaminia
    Rocco, Monica
    Marchetti, Paolo
    Mura, Cameron
    Simmaco, Maurizio
    Bourne, Philip E.
    Preissner, Robert
    Banerjee, Priyanka
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [42] Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach
    Lima, Adrianne M.
    de Souza, Adson A.
    Amaral, Jackson L.
    Freire, Valder N.
    Souza, Pedro F.
    de Oliveira, Hermogenes D.
    FUTURE VIROLOGY, 2023, 18 (07) : 439 - 454
  • [43] QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors
    Nandi, Sisir
    Kumar, Mohit
    Saxena, Anil Kumar
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (01) : 116 - 132
  • [44] Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors
    Tan, Bin
    Sacco, Michael
    Tan, Haozhou
    Li, Kan
    Joyce, Ryan
    Zhang, Xiujun
    Chen, Yu
    Wang, Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [45] A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
    Geng, Zhi Zachary
    Atla, Sandeep
    Shaabani, Namir
    Vulupala, Veerabhadra
    Yang, Kai S.
    Alugubelli, Yugendar R.
    Khatua, Kaustav
    Chen, Peng-Hsun
    Xiao, Jing
    Blankenship, Lauren R.
    Ma, Xinyu R.
    Vatansever, Erol C.
    Cho, Chia-Chuan D.
    Ma, Yuying
    Allen, Robert
    Ji, Henry
    Xu, Shiqing
    Liu, Wenshe Ray
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 11040 - 11055
  • [46] Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
    Jimenez-Alberto, Alicia
    Maria Ribas-Aparicio, Rosa
    Aparicio-Ozores, Gerardo
    Castelan-Vega, Juan A.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 88 (88)
  • [47] Action of Dipeptidyl Peptidase-4 Inhibitors on SARS-CoV-2 Main Protease
    Nar, Herbert
    Schnapp, Gisela
    Hucke, Oliver
    Hardman, Timothy C.
    Klein, Thomas
    CHEMMEDCHEM, 2021, 16 (09) : 1425 - 1426
  • [48] Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
    Kneller, Daniel W.
    Li, Hui
    Phillips, Gwyndalyn
    Weiss, Kevin L.
    Zhang, Qiu
    Arnould, Mark A.
    Jonsson, Colleen B.
    Surendranathan, Surekha
    Parvathareddy, Jyothi
    Blakeley, Matthew P.
    Coates, Leighton
    Louis, John M.
    Bonnesen, Peter, V
    Kovalevsky, Andrey
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [49] An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease
    Djokovic, Nemanja
    Ruzic, Dusan
    Djikic, Teodora
    Cvijic, Sandra
    Ignjatovic, Jelisaveta
    Ibric, Svetlana
    Baralic, Katarina
    Buha Djordjevic, Aleksandra
    Curcic, Marijana
    Djukic-Cosic, Danijela
    Nikolic, Katarina
    MOLECULAR INFORMATICS, 2021, 40 (05)
  • [50] Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
    Cardoso, Wesley B.
    Mendanha, Sebastiao A.
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1225
12345